{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:56:34Z","timestamp":1781459794249,"version":"3.54.1"},"reference-count":33,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Perfusion"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) with stenting is standard of care but increases bleeding risk, particularly in patients requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for acute myocardial infarction\u2013cardiogenic shock. Evidence guiding optimal antithrombotic strategies in this high-risk population remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective observational study at a high-volume ECMO center. From January 2018 to December 2022, 351 VA-ECMO patients were screened, and 72 who underwent PCI immediately prior to or during ECMO were included. Patients were grouped by initial post-PCI antiplatelet strategy: aspirin alone (n = 33), augmented therapy (n = 25), or no antiplatelet therapy (n = 14). The primary objective was to evaluate the safety and efficacy of an aspirin-only strategy for preventing in-stent thrombosis. Efficacy was assessed by the incidence of in-stent thrombosis during ECMO hospitalization, and safety was assessed by the occurrence of major bleeding events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Groups were similar in age, race, gender, and BMI. No patient developed clinically overt in-stent thrombosis. Major bleeding occurred in 33.3% of aspirin, 48% of augmented, and 50% of no-antiplatelet patients (p = 0.396). Most common bleeding events were hemoptysis, intracranial hemorrhage, and gastrointestinal bleeding.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients undergoing PCI with concurrent VA-ECMO support, no differences in stent thrombosis or major bleeding were observed between aspirin monotherapy, augmented antiplatelet therapy, or no antiplatelet therapy. However, intracranial hemorrhage occurred more frequently in the Augmented AP group. These findings suggest that aspirin monotherapy may provide adequate protection against stent thrombosis while potentially minimizing bleeding risk in this critically ill population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/02676591261459249","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T21:21:52Z","timestamp":1781126512000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of single antiplatelet therapy with anticoagulation in patients with AMI\u2013cardiogenic shock requiring VA-ECMO"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1069-0661","authenticated-orcid":false,"given":"Junad M","family":"Chowdhury","sequence":"first","affiliation":[{"name":"Inova Fairfax Medical Campus"},{"name":"Inova Schar Heart and Vascular"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ferri","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Looby","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhimanyu","family":"Chandel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Uniformed Services University of the Health Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehul","family":"Desai","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Critical Care, Advent Health, Orlando, FL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Albertina","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Gannon","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl D","family":"Young","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Franke","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Barker","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Clevenger","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Brad","family":"Lee","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benham N.","family":"Tehrani","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Singh","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Vavilin","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutaz","family":"Alkalbani","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"King","sequence":"additional","affiliation":[{"name":"Inova Fairfax Medical Campus"},{"name":"Inova Schar Heart and Vascular"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Vandenbriele","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield Hospitals"},{"name":"Guys and St Thomas\u2019 NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Truesdell","sequence":"additional","affiliation":[{"name":"Virginia Heart"},{"name":"Inova Schar Heart and Vascular"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2023.06.026"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312572"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175576"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2021.01.056"},{"key":"e_1_3_6_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1594.2010.01173.x"},{"key":"e_1_3_6_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05897-3"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-024-07515-3"},{"key":"e_1_3_6_9_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-011551"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13497"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.22172"},{"key":"e_1_3_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001869"},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186067"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"e_1_3_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.052"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.022125"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.2174\/1381612823666170124141806"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2003.12.001"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.4244\/EIJ-D-21-00904"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2016.04.037"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.322752"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.76.1.125"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002589"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020496"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1817083"},{"issue":"3","key":"e_1_3_6_26_2","first-page":"100607","article-title":"Antiplatelet strategies following PCI: a review of trials informing current and future therapies","volume":"2","author":"Thomas A","year":"2023","unstructured":"Thomas A, Gitto M, Shah S, et al. Antiplatelet strategies following PCI: a review of trials informing current and future therapies. J Soc Cardiovasc Angiogr Interv 2023; 2(3): 100607. https:\/\/doi.org\/10.1016\/j.jscai.2023.100607","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"key":"e_1_3_6_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.93.4.667"},{"key":"e_1_3_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.055"},{"key":"e_1_3_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90590-8"},{"key":"e_1_3_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154216"},{"key":"e_1_3_6_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-022-01664-0"},{"key":"e_1_3_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2024.154771"},{"key":"e_1_3_6_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001230"},{"key":"e_1_3_6_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159973"}],"container-title":["Perfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02676591261459249","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/02676591261459249","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/02676591261459249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:07:59Z","timestamp":1781456879000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/02676591261459249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":33,"alternative-id":["10.1177\/02676591261459249"],"URL":"https:\/\/doi.org\/10.1177\/02676591261459249","relation":{},"ISSN":["0267-6591","1477-111X"],"issn-type":[{"value":"0267-6591","type":"print"},{"value":"1477-111X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"02676591261459249"}}